vs
ASTRONICS CORP（ATRO）与Tarsus Pharmaceuticals, Inc.（TARS）财务数据对比。点击上方公司名可切换其他公司
ASTRONICS CORP的季度营收约是Tarsus Pharmaceuticals, Inc.的1.6倍（$240.1M vs $151.7M），Tarsus Pharmaceuticals, Inc.同比增速更快（128.4% vs 15.1%），ASTRONICS CORP自由现金流更多（$15.8M vs $13.0M），过去两年Tarsus Pharmaceuticals, Inc.的营收复合增速更高（134.4% vs 13.9%）
Astronics Corporation是一家成立于1968年的美国航空航天电子企业，总部位于纽约州东奥罗拉，在纳斯达克上市，股票代码为ATRO。该公司专注于军用、商用及公务机的照明与电子系统集成业务，同时还提供半导体测试系统，在相关领域拥有较高知名度。
Tarsus Pharmaceuticals是一家处于后期临床阶段的生物制药公司，专注于眼科、皮肤科等专科领域创新疗法的研发和商业化，主打产品针对蠕形螨睑缘炎、玫瑰痤疮等未被充分诊断的常见病症，核心市场为美国。
ATRO vs TARS — 直观对比
营收规模更大
ATRO
是对方的1.6倍
$151.7M
营收增速更快
TARS
高出113.3%
15.1%
自由现金流更多
ATRO
多$2.8M
$13.0M
两年增速更快
TARS
近两年复合增速
13.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $240.1M | $151.7M |
| 净利润 | — | $-8.4M |
| 毛利率 | 33.3% | — |
| 营业利润率 | 14.8% | -5.3% |
| 净利率 | — | -5.5% |
| 营收同比 | 15.1% | 128.4% |
| 净利润同比 | — | 63.8% |
| 每股收益（稀释后） | $0.82 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATROTARS
| Q4 25 | $240.1M | $151.7M | ||
| Q3 25 | $211.4M | $118.7M | ||
| Q2 25 | $204.7M | $102.7M | ||
| Q1 25 | $205.9M | $78.3M | ||
| Q4 24 | $208.5M | $66.4M | ||
| Q3 24 | $203.7M | $48.1M | ||
| Q2 24 | $198.1M | $40.8M | ||
| Q1 24 | $185.1M | $27.6M |
净利润ATROTARS
| Q4 25 | — | $-8.4M | ||
| Q3 25 | $-11.1M | $-12.6M | ||
| Q2 25 | $1.3M | $-20.3M | ||
| Q1 25 | $9.5M | $-25.1M | ||
| Q4 24 | — | $-23.1M | ||
| Q3 24 | $-11.7M | $-23.4M | ||
| Q2 24 | $1.5M | $-33.3M | ||
| Q1 24 | $-3.2M | $-35.7M |
毛利率ATROTARS
| Q4 25 | 33.3% | — | ||
| Q3 25 | 30.5% | — | ||
| Q2 25 | 25.8% | — | ||
| Q1 25 | 29.5% | — | ||
| Q4 24 | 29.8% | — | ||
| Q3 24 | 27.1% | — | ||
| Q2 24 | 28.0% | — | ||
| Q1 24 | 25.7% | — |
营业利润率ATROTARS
| Q4 25 | 14.8% | -5.3% | ||
| Q3 25 | 10.9% | -12.2% | ||
| Q2 25 | 2.3% | -21.6% | ||
| Q1 25 | 6.4% | -33.5% | ||
| Q4 24 | 4.3% | -36.8% | ||
| Q3 24 | 4.1% | -52.3% | ||
| Q2 24 | 3.8% | -81.6% | ||
| Q1 24 | 0.9% | -136.5% |
净利率ATROTARS
| Q4 25 | — | -5.5% | ||
| Q3 25 | -5.2% | -10.6% | ||
| Q2 25 | 0.6% | -19.8% | ||
| Q1 25 | 4.6% | -32.1% | ||
| Q4 24 | — | -34.8% | ||
| Q3 24 | -5.8% | -48.7% | ||
| Q2 24 | 0.8% | -81.6% | ||
| Q1 24 | -1.7% | -129.4% |
每股收益（稀释后）ATROTARS
| Q4 25 | $0.82 | $-0.17 | ||
| Q3 25 | $-0.31 | $-0.30 | ||
| Q2 25 | $0.04 | $-0.48 | ||
| Q1 25 | $0.26 | $-0.64 | ||
| Q4 24 | $-0.07 | $-0.57 | ||
| Q3 24 | $-0.34 | $-0.61 | ||
| Q2 24 | $0.04 | $-0.88 | ||
| Q1 24 | $-0.09 | $-1.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $18.2M | $417.3M |
| 总债务越低越好 | — | $72.4M |
| 股东权益账面价值 | $140.1M | $343.4M |
| 总资产 | $706.7M | $562.2M |
| 负债/权益比越低杠杆越低 | — | 0.21× |
8季度趋势，按日历期对齐
现金及短期投资ATROTARS
| Q4 25 | $18.2M | $417.3M | ||
| Q3 25 | $13.5M | $401.8M | ||
| Q2 25 | $13.5M | $381.1M | ||
| Q1 25 | $24.8M | $407.9M | ||
| Q4 24 | $9.3M | $291.4M | ||
| Q3 24 | $5.2M | $317.0M | ||
| Q2 24 | $2.9M | $323.6M | ||
| Q1 24 | $5.3M | $298.5M |
总债务ATROTARS
| Q4 25 | — | $72.4M | ||
| Q3 25 | — | $72.3M | ||
| Q2 25 | — | $72.1M | ||
| Q1 25 | — | $72.0M | ||
| Q4 24 | — | $71.8M | ||
| Q3 24 | — | $71.7M | ||
| Q2 24 | — | $71.6M | ||
| Q1 24 | — | $29.9M |
股东权益ATROTARS
| Q4 25 | $140.1M | $343.4M | ||
| Q3 25 | $108.9M | $335.1M | ||
| Q2 25 | $271.6M | $332.6M | ||
| Q1 25 | $266.8M | $342.5M | ||
| Q4 24 | $256.1M | $224.5M | ||
| Q3 24 | $249.2M | $237.5M | ||
| Q2 24 | $257.9M | $252.2M | ||
| Q1 24 | $251.7M | $275.2M |
总资产ATROTARS
| Q4 25 | $706.7M | $562.2M | ||
| Q3 25 | $682.2M | $534.6M | ||
| Q2 25 | $646.7M | $495.0M | ||
| Q1 25 | $662.2M | $500.8M | ||
| Q4 24 | $648.8M | $377.0M | ||
| Q3 24 | $651.6M | $376.3M | ||
| Q2 24 | $644.9M | $376.8M | ||
| Q1 24 | $630.0M | $349.3M |
负债/权益比ATROTARS
| Q4 25 | — | 0.21× | ||
| Q3 25 | — | 0.22× | ||
| Q2 25 | — | 0.22× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.30× | ||
| Q2 24 | — | 0.28× | ||
| Q1 24 | — | 0.11× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.6M | $19.3M |
| 自由现金流经营现金流 - 资本支出 | $15.8M | $13.0M |
| 自由现金流率自由现金流/营收 | 6.6% | 8.6% |
| 资本支出强度资本支出/营收 | 4.9% | 4.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $43.1M | $-22.3M |
8季度趋势，按日历期对齐
经营现金流ATROTARS
| Q4 25 | $27.6M | $19.3M | ||
| Q3 25 | $34.2M | $18.3M | ||
| Q2 25 | $-7.6M | $-29.4M | ||
| Q1 25 | $20.6M | $-20.7M | ||
| Q4 24 | $26.4M | $-22.2M | ||
| Q3 24 | $8.4M | $-8.7M | ||
| Q2 24 | $-6.3M | $-14.4M | ||
| Q1 24 | $2.0M | $-37.8M |
自由现金流ATROTARS
| Q4 25 | $15.8M | $13.0M | ||
| Q3 25 | $21.0M | $16.3M | ||
| Q2 25 | $-12.2M | $-30.4M | ||
| Q1 25 | $18.5M | $-21.2M | ||
| Q4 24 | $23.2M | $-22.3M | ||
| Q3 24 | $6.5M | $-8.9M | ||
| Q2 24 | $-8.1M | $-15.4M | ||
| Q1 24 | $439.0K | $-38.0M |
自由现金流率ATROTARS
| Q4 25 | 6.6% | 8.6% | ||
| Q3 25 | 9.9% | 13.8% | ||
| Q2 25 | -6.0% | -29.6% | ||
| Q1 25 | 9.0% | -27.1% | ||
| Q4 24 | 11.1% | -33.5% | ||
| Q3 24 | 3.2% | -18.6% | ||
| Q2 24 | -4.1% | -37.8% | ||
| Q1 24 | 0.2% | -137.5% |
资本支出强度ATROTARS
| Q4 25 | 4.9% | 4.2% | ||
| Q3 25 | 6.2% | 1.6% | ||
| Q2 25 | 2.2% | 1.0% | ||
| Q1 25 | 1.0% | 0.8% | ||
| Q4 24 | 1.5% | 0.1% | ||
| Q3 24 | 0.9% | 0.6% | ||
| Q2 24 | 0.9% | 2.5% | ||
| Q1 24 | 0.9% | 0.6% |
现金转化率ATROTARS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -5.81× | — | ||
| Q1 25 | 2.17× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -4.08× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATRO
| Product Line Electrical Power And Motion | $113.8M | 47% |
| Product Line Avionics | $32.0M | 13% |
| Military Aircraft | $28.0M | 12% |
| General Aviation | $22.3M | 9% |
| Government And Defense | $20.5M | 9% |
| Product Line Systems Certification | $13.2M | 6% |
| Product Line Structures | $3.7M | 2% |
| Product Line Other | $2.3M | 1% |
TARS
暂无分部数据
